Delivery Order SPE2DR25D1004-SPE2DR26FSWB7
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,594.36 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Repatha is a prescription medication used to lower cholesterol levels and reduce the...
- The Defense Logistics Agency awarded a delivery order valued at $9,864.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with a completion deadline of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $13,727.57 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. This non-competitive, firm fixed-price delivery order was awarded on September 9, 2025, with a completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Repatha (evolocumab) is a PCSK9 inhibitor used to lower cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a delivery order valued at $1,962.21 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels, and this delivery...
- The Defense Logistics Agency awarded a $19,632.10 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens under contract 4569852163. This non-competitive, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol...
- The Defense Logistics Agency awarded a delivery order valued at $10,015.20 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick autoinjector pens, with an ultimate completion date of August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor indicated for cardiovascular disease management, representing a specialty...
- The Defense Logistics Agency awarded a delivery order valued at $91,189.21 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price, non-set-aside contract was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients at risk for...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on August 1, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $18,803.69 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for October 23, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed price terms and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Repatha is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $22,421.56 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients at risk...